Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Dreyling
M
M
Department of Medicine III, University Hospital Grosshadern, LMU Munich, Germany.
D015492:AIDS Serodiagnosis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001707:Biopsy, Needle; D018572:Disease-Free Survival; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006509:Hepatitis B / Q000175:diagnosis; D006801:Humans; D015994:Incidence; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008197:Lymph Node Excision; D008224:Lymphoma, Follicular / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D015201:Meta-Analysis as Topic; D009367:Neoplasm Staging; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012074:Remission Induction; D018570:Risk Assessment; D016896:Treatment Outcome; D014527:Uric Acid / Q000032:analysis
D000911:Antibodies, Monoclonal; D006454:Hemoglobins; D014527:Uric Acid; D007770:L-Lactate Dehydrogenase